Author - Antonette Ho

Windgap Medical Appoints Aaron Mann as CEO, Michael Samar as CFO

Windgap Medical announced today it has appointed Aaron Mann as the company's Chief Executive Officer and Michael Samar as the company's Chief Financial Officer, effective February 1. Both bring significant industry tenure and experience to their roles, and with Windgap Co-Founder Brent Buchine, will lead the company's continued growth in the field of complex injectable drug delivery solutions. "Aaron Mann brings a depth of industry experience that is a strong complement to the scientific and technical team in place today...
Read more...

EarthGrid, PBC Wins ‘Most Fundable Company’ Award from Pepperdine Graziadio Business School

EarthGrid, PBC is excited to announce that it won Platinum recognition — the highest honor — on the Pepperdine Graziadio Business School’s fifth annual Most Fundable Companies® List. EarthGrid competed against 4,000-plus early-stage U.S. companies before earning a coveted Platinum spot among 16 finalists. The Most Fundable Companies initiative educates on the investor diligence process and recognizes exceptional entrepreneurs who are solving problems with inventive solutions and are also seeking investment capital. Watch EarthGrid’s presentation. Troy Helming, Founder and CEO...
Read more...

4 reasons why it matters to replace our plastic cutlery with biodegradable one as a path to sustainability

Biodegradable cutlery that is predominantly resourced from natural materials like corn starch, sugarcane, or bamboo decomposes quickly and necessitates no chemical usage during the entire manufacturing process. “Disposable plastic products have posed a detrimental impact on the environment for decades now, with estimates showing that around nine million metric tonnes of plastic end up in the ocean each year. Hence, plastic disposables are not a viable long-term solution, as plastic makes up more than 80% of marine litter, and 70%...
Read more...

MyoPro Approved in Australia by National Disability Insurance Scheme

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced that for the first time, the National Disability Insurance Scheme (NDIS) in Australia approved a MyoPro for a patient with a paralyzed arm. The NDIS aids over 500,000 Australians with disabilities through reimbursement for necessary services and support. The patented MyoPro technology was developed by Myomo in collaboration with researchers at the Massachusetts Institute of Technology and Harvard Medical...
Read more...

Myomo Appoints Yitzchak Jacobovitz to its Board of Directors

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of Yitzchak Jacobovitz as a Class II director effective January 27, 2023, to serve until the 2025 annual meeting of stockholders. With this appointment, Myomo has six directors. “We welcome Yitz to the Myomo Board of Directors and are gratified that AIGH was the lead investor in our most recent equity offering,” said Paul R. Gudonis,...
Read more...

Immusoft Awarded $8M in Funding from the California Institute for Regenerative Medicine (CIRM) for MPS I Clinical Program

Immusoft of CA, a wholly owned subsidiary of Immusoft Corporation, a clinical-stage cell therapy company dedicated to improving the lives of patients with rare or genetic diseases, announced today that the California Institute for Regenerative Medicine (CIRM) has awarded the company an $8M grant. This funding will support a Phase I study to evaluate the safety and tolerability of ISP-001 (for delivery of alpha-L-iduronidase, or IDUA) in MPS I a rare, childhood genetic disease. The Investigational New Drug Application for...
Read more...

Researchers confirm successful rehabilitation and recovery of human donor lungs previously deemed unfit for transplant

A novel method for supporting and recovering donor lungs outside the body shows potential to increase the number of organs available for transplant, according to a recent study published in The Journal of Heart and Lung Transplantation. The organ shortage crisis is increasingly dire, as thousands of patients die every year waiting to receive donor organs. Despite urgent demand, nearly 80% of donated lungs are too damaged for transplantation, often due to reversible conditions. A cross-disciplinary team of surgeons and...
Read more...

Akston Biosciences Strengthens Board with Addition of John T. Preston

Akston Biosciences Corporation, a clinical-stage biotechnology company, today announced that John T. Preston, a founder of TEM Capital, has joined its Board of Directors. A recipient of numerous awards and previous advisor to several government agencies and expert witness for Congress, Preston brings to Akston his decades of experience in technology commercialization and intellectual property licensing. Preston spent most of his career at the Massachusetts Institute of Technology (MIT), managing the interface between researchers and industry. His titles included Associate...
Read more...

So Long Mic!

Ziad Moukheiber, Boston Harbor Angels and the angel investing community are sad to announce that Mic Williams took his last ride into the sunset. Mic was the Founder of Boston Harbor Angels, a leading angel investing group in the Boston area and a pioneer in angel investing. As an early member of the Angel Capital Association, Mic was a pillar of the community. Lucky are the ones who had the opportunity to have a drink with Mic and the ACA regulars,...
Read more...

OmniLife Health’s Clinical Workflow Automation Platform Enhances Capabilities Within Organ Transplant, Expands into Complex Healthcare Environments

OmniLife Health, a leader in clinical workflow automation enabling healthcare teams to improve outcomes, enhance efficiencies, reduce costs and improve revenue capture, has expanded its FlowHawk™ platform into additional complex healthcare environments. First developed as a HIPAA-compliant messaging solution for transplant teams, FlowHawk has evolved into an end-to-end platform that automates clinical workflows for organ transplant, organ failure care, oncology, and complex care verticals. FlowHawk’s expansion is timely; a Becker’s Healthcare survey commissioned by OmniLife Health showed adoption of clinical...
Read more...